ABBV

2025Q4BMO

AbbVie Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-02-04 · Fiscal end 2025-12-31 · Features as of 2026-02-03

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.65
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.9%
IV front—
P/C full—
P/C front—
Features as of2026-02-03

Run-up

Close—
Ret 5d+0.8%
Ret 10d+5.4%
Ret 20d+2.5%
Ret 30d+1.3%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.71Beat
Estimated EPS2.65
Actual revenue
16.6B
Surprise %+2.3%
Beat / missBeat
Beat streak 44
Beat streak 86

Reaction

1-day stock reaction+3.5%
Implied vs actual

Implied 1.9%Actual 7.0%

Gap reaction-7.0%
Day result-3.8%
Next-day upYes
Realized / IV3.77×

Post tape

Post 5d+1.7%
Post 10d+3.3%
Post volume15.3M
Vol ×10d2.27×
Vol ×20d2.09×
Post range7.9%